查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672681

全球荷尔蒙补充疗法市场按治疗类型、给药途径、应用、分销管道和地区划分

Hormone Replacement Therapy Market, By Therapy Type, By Route of Administration, By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球荷尔蒙补充疗法市场规模估计为 157.8 亿美元，预计到 2032 年将达到 237.5 亿美元，2025 年至 2032 年的复合年增长率为 6.0%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 157.8亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 6.00％ 2032 年价值预测 237.5亿美元
数字。 2025 年荷尔蒙补充疗法市场占有率（%），按地区划分
荷尔蒙替代疗法市场-IMG1

由于全球女性更年期症状的盛行率不断上升，全球荷尔蒙补充疗法市场在过去几年中经历了显着增长。荷尔蒙补充疗法可以帮助治疗更年期后出现的许多症状，包括潮热、盗汗、阴道干燥、性慾减退和情绪低落。人们对骨质疏鬆症和其他与荷尔蒙失衡和老龄化有关的慢性疾病的健康问题日益担忧，推动了对有效治疗方案的需求。此外，人们对女性健康问题的认识不断提高以及各种荷尔蒙替代製剂的普及预计将在预测期内推动市场扩张。然而，长期使用荷尔蒙药物的副作用以及替代治疗方案的可用性等因素可能会继续在一定程度上阻碍市场成长。

市场动态：

推动全球荷尔蒙补充疗法市场发展的关键因素包括易患荷尔蒙缺乏症的老年人口快速增加、女性更年期症状发病率上升、全球文明病激增以及人们对荷尔蒙补充疗法在管理慢性病方面的益处的认识不断提高。另一方面，长期使用荷尔蒙药物所带来的副作用，包括乳癌、心臟病、中风和血栓，对市场相关人员构成了重大挑战。然而，持续进行的新型药物输送系统、各种激素组合以及生物同质激素配方创新的研究和开发预计将在未来几年为相关人员提供丰厚的成长机会。

本研究的主要特点

  • 本报告对全球荷尔蒙补充疗法市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和复合年增长率。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
  • 全球荷尔蒙补充疗法市场的主要企业是根据公司亮点、产品系列、关键亮点、业绩和策略等参数列出的。
  • 主要企业包括诺华公司、雅培公司、迈兰公司、默克公司、拜耳公司、辉瑞公司、诺和诺德公司、QuatRx Pharmaceuticals、梯瓦製药工业有限公司、安进公司、礼来公司、Halozyme Therapeutics 公司、艾伯维公司、Noven Pharmaceuticals 公司和 i-MAB Bioph 公司。
  • 本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球荷尔蒙补充疗法市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球荷尔蒙补充疗法市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 製造商收益
  • 采用非侵入式感测器技术
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章。全球荷尔蒙补充疗法市场：COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 全球荷尔蒙补充疗法市场按治疗类型划分（2020-2032 年）

  • 雌激素替代疗法
  • 人体生长荷尔蒙(HGH) 替代疗法
  • 甲状腺替代疗法
  • 睾酮替代疗法
  • 其他的

6. 全球荷尔蒙补充疗法市场按给药途径划分（2020-2032 年）

  • 口服
  • 肠外
  • 其他的

7. 全球荷尔蒙补充疗法市场按应用划分（2020-2032 年）

  • 甲状腺机能低下症
  • 男性性腺功能低下症
  • 生长激素缺乏
  • 其他的

8. 全球荷尔蒙补充疗法市场按分销管道划分（2020-2032 年）

  • 院内药房
  • 零售药局
  • 网路药局

9. 全球荷尔蒙补充疗法市场（按地区） (2020-2032)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • Novartis AG
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

第 11 章 分析师观点

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map（COM）

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2079

Global Hormone Replacement Therapy Market is estimated to be valued at USD 15.78 Bn in 2025 and is expected to reach USD 23.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 15.78 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.00% 2032 Value Projection: USD 23.75 Bn
Figure. Hormone Replacement Therapy Market Share (%), By Region 2025
Hormone Replacement Therapy Market - IMG1

The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics:

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation-

  • By Therapy Type:
    • Estrogen Replacement Therapy
    • Human Growth Hormone (HGH) Replacement Therapy
    • Thyroid Replacement Therapy
    • Testosterone Replacement Therapy
    • Others
  • By Route of Administration:
    • Oral
    • Parenteral
    • Others
  • By Application:
    • Hypothyroidism
    • Male Hypogonadism
    • Growth Hormone Deficiency
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Novartis AG
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Adoption of Non-invasive Sensor Technologies
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Estrogen Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Human Growth Hormone (HGH) Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thyroid Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Testosterone Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Hormone Replacement Therapy Market, By Route of Administration, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Hormone Replacement Therapy Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypothyroidism
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Male Hypogonadism
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Growth Hormone Deficiency
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Hormone Replacement Therapy Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Novartis AG*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

11. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact